A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Researchers have uncovered multiple new genes and genetic pathways that could lead to repurposing hundreds of existing drugs ...